Agenus (AGEN) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

AGEN Stock Forecast

Agenus stock forecast is as follows: an average price target of $7.33 (represents a 159.01% upside from AGEN’s last price of $2.83) and a rating consensus of 'Hold', based on 4 wall street analysts offering a 1-year stock forecast.

AGEN Price Target

The average price target for Agenus (AGEN) is $7.33 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $8.00 to $7.00. This represents a potential 159.01% upside from AGEN's last price of $2.83.

AGEN Analyst Ratings

Hold

According to 4 Wall Street analysts, Agenus's rating consensus is 'Hold'. The analyst rating breakdown for AGEN stock is 0 'Strong Buy' (0.00%), 1 'Buy' (25.00%), 3 'Hold' (75.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Agenus Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 29, 2024	Emily Bodnar	H.C. Wainwright	$7.00	$3.57	96.00%	147.35%
Jul 19, 2024	Biren Amin	Jefferies	$7.00	$5.99	16.86%	147.35%
Jul 19, 2024	Colleen Kusy	Robert W. Baird	$8.00	$7.30	9.59%	182.69%
Jul 18, 2024	Emily Bodnar	H.C. Wainwright	$9.00	$7.98	12.85%	218.02%
Jul 01, 2024	Emily Bodnar	H.C. Wainwright	$20.00	$8.38	138.66%	606.71%

The latest Agenus stock forecast, released on Nov 29, 2024 by Emily Bodnar from H.C. Wainwright, set a price target of $7.00, which represents a 96.00% increase from the stock price at the time of the forecast ($3.57), and a 147.35% increase from AGEN last price ($2.83).

Agenus Price Target by Period

	1M	3M	12M
# Anlaysts	1	1	5
Avg Price Target	$7.00	$7.00	$10.20
Last Closing Price	$2.83	$2.83	$2.83
Upside/Downside	147.35%	147.35%	260.42%

In the current month, the average price target of Agenus stock is $7.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 147.35% increase as opposed to Agenus's last price of $2.83. This month's average price target is down 0.00% compared to last quarter, and down -31.37% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Nov 29, 2024	H.C. Wainwright	Neutral	Neutral	Hold
Aug 14, 2024	B. Riley	Buy	Buy	Hold
Jul 19, 2024	Jefferies		Hold	Downgrade
Jul 18, 2024	William Blair		Market Perform	Downgrade
Jul 18, 2024	H.C. Wainwright	Buy	Neutral	Downgrade
Jul 01, 2024	H.C. Wainwright	Buy	Buy	Hold

Agenus's last stock rating was published by H.C. Wainwright on Nov 29, 2024. The company gave AGEN a "Neutral" rating, the same as its previous rate.

Agenus Financial Forecast

Agenus Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$83.80M	$24.31M	$25.30M	$22.90M	$28.39M	$22.77M	$20.93M	$25.94M	$20.26M	$252.95M	$10.73M	$11.72M	$31.26M	$14.83M	$26.95M	$15.13M	$34.50M	$19.94M
Avg Forecast	$96.42M	$92.53M	$86.73M	$80.91M	$43.39M	$51.44M	$51.17M	$25.91M	$31.99M	$33.48M	$63.48M	$47.17M	$47.05M	$24.33M	$24.13M	$22.98M	$17.83M	$20.69M	$18.70M	$11.80M	$37.74M	$183.10M	$20.41M	$14.53M	$16.23M	$14.00M	$9.33M	$12.35M	$13.03M	$15.60M
High Forecast	$144.84M	$138.99M	$130.27M	$121.53M	$65.17M	$77.27M	$76.86M	$38.36M	$46.15M	$50.28M	$63.48M	$47.17M	$64.49M	$24.33M	$36.25M	$34.51M	$26.77M	$20.69M	$18.70M	$11.80M	$37.74M	$183.10M	$20.41M	$14.53M	$16.23M	$14.00M	$9.33M	$12.35M	$13.03M	$15.60M
Low Forecast	$61.19M	$58.72M	$55.04M	$51.34M	$27.53M	$32.65M	$32.47M	$13.45M	$23.79M	$21.24M	$63.48M	$47.17M	$22.42M	$24.33M	$15.31M	$14.58M	$11.31M	$20.69M	$18.70M	$11.80M	$37.74M	$183.10M	$20.41M	$14.53M	$16.23M	$14.00M	$9.33M	$12.35M	$13.03M	$15.60M
# Analysts	1	1	1	1	1	1	1	2	4	2	1	1	3	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	8	8
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.78%	1.00%	1.05%	1.00%	1.59%	1.10%	1.12%	2.20%	0.54%	1.38%	0.53%	0.81%	1.93%	1.06%	2.89%	1.22%	2.65%	1.28%

Agenus's average Quarter revenue forecast for Mar 24 based on 1 analysts is $47.17M, with a low forecast of $47.17M, and a high forecast of $47.17M. AGEN's average Quarter revenue forecast represents a -43.71% decrease compared to the company's last Quarter revenue of $83.80M (Dec 23).

Agenus EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	4	2	1	1	3	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	8	8
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-4.36M	$442.00K	$2.14M	$-52.15M	$-52.82M	$-39.41M	$-34.22M	$-34.28M	$-47.28M	$196.81M	$-64.89M	$-36.06M	$-19.57M	$-33.09M	$-31.06M	$-28.94M	$-16.54M	$-33.14M
Avg Forecast	$-61.86M	$-59.36M	$-55.64M	$-51.90M	$-27.83M	$-33.00M	$-32.83M	$-16.62M	$-20.52M	$-21.47M	$-40.72M	$-37.59M	$-30.19M	$-15.61M	$-15.48M	$-40.21M	$-14.53M	$-13.06M	$-11.80M	$-43.00M	$-23.82M	$-115.56M	$-12.88M	$-40.71M	$-10.24M	$-8.84M	$-5.89M	$-30.69M	$-8.22M	$-9.85M
High Forecast	$-39.25M	$-37.67M	$-35.31M	$-32.94M	$-17.66M	$-20.94M	$-20.83M	$-8.63M	$-15.26M	$-13.63M	$-40.72M	$-30.08M	$-14.38M	$-15.61M	$-9.82M	$-32.17M	$-11.62M	$-13.06M	$-11.80M	$-34.40M	$-23.82M	$-115.56M	$-12.88M	$-32.57M	$-10.24M	$-8.84M	$-5.89M	$-24.55M	$-8.22M	$-9.85M
Low Forecast	$-92.91M	$-89.16M	$-83.57M	$-77.96M	$-41.81M	$-49.57M	$-49.31M	$-24.61M	$-29.60M	$-32.26M	$-40.72M	$-45.11M	$-41.37M	$-15.61M	$-23.25M	$-48.25M	$-17.43M	$-13.06M	$-11.80M	$-51.60M	$-23.82M	$-115.56M	$-12.88M	$-48.85M	$-10.24M	$-8.84M	$-5.89M	$-36.83M	$-8.22M	$-9.85M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.14%	-0.03%	-0.14%	1.30%	3.64%	3.02%	2.90%	0.80%	1.99%	-1.70%	5.04%	0.89%	1.91%	3.75%	5.28%	0.94%	2.01%	3.37%

3 analysts predict AGEN's average Quarter EBITDA for Dec 23 to be $-30.19M, with a high of $-14.38M and a low of $-41.37M. This is -6929.29% lower than Agenus's previous annual EBITDA (Sep 23) of $442.00K.

Agenus Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	4	2	1	1	3	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	8	8
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-48.58M	$-62.25M	$-69.07M	$-67.85M	$-97.40M	$-74.28M	$-51.10M	$-63.47M	$-84.18M	$178.55M	$-83.29M	$-53.68M	$-37.61M	$-51.15M	$-47.48M	$-44.67M	$-30.05M	$-45.47M
Avg Forecast	$-41.36M	$-43.45M	$-47.36M	$-51.63M	$-47.70M	$-41.81M	$-39.44M	$-52.58M	$-56.85M	$-49.86M	$-22.99M	$-57.74M	$-23.00M	$-84.07M	$-84.05M	$-61.75M	$-15.03M	$-77.51M	$-95.07M	$-66.04M	$-65.10M	$188.77M	$-100.59M	$-60.60M	$-90.94M	$-107.47M	$-112.99M	$-47.38M	$-157.08M	$-157.08M
High Forecast	$-21.71M	$-22.81M	$-24.87M	$-27.10M	$-25.04M	$-21.95M	$-20.70M	$-45.90M	$-35.76M	$-26.18M	$-12.07M	$-46.19M	$7.67M	$-44.14M	$-44.12M	$-49.40M	$-12.02M	$-77.51M	$-95.07M	$-52.84M	$-65.10M	$188.77M	$-100.59M	$-48.48M	$-90.94M	$-107.47M	$-112.99M	$-37.91M	$-157.08M	$-157.08M
Low Forecast	$-68.35M	$-71.81M	$-78.28M	$-85.32M	$-78.83M	$-69.09M	$-65.18M	$-62.50M	$-66.25M	$-82.40M	$-37.99M	$-69.28M	$-57.51M	$-138.95M	$-138.90M	$-74.10M	$-18.04M	$-77.51M	$-95.07M	$-79.25M	$-65.10M	$188.77M	$-100.59M	$-72.72M	$-90.94M	$-107.47M	$-112.99M	$-56.86M	$-157.08M	$-157.08M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	2.11%	0.74%	0.82%	1.10%	6.48%	0.96%	0.54%	0.96%	1.29%	0.95%	0.83%	0.89%	0.41%	0.48%	0.42%	0.94%	0.19%	0.29%

Agenus's average Quarter net income forecast for Dec 21 is $-65.10M, with a range of $-65.10M to $-65.10M. AGEN's average Quarter net income forecast represents a -136.46% decrease compared to the company's last Quarter net income of $178.55M (Sep 21).

Agenus SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	4	2	1	1	3	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	8	8
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$21.18M	$18.91M	$20.41M	$18.24M	$25.04M	$18.11M	$18.91M	$18.95M	$21.97M	$21.39M	$16.65M	$16.35M	$20.03M	$14.38M	$14.20M	$10.61M	$12.32M	$11.51M
Avg Forecast	$49.50M	$47.50M	$44.52M	$41.53M	$22.27M	$26.41M	$26.27M	$13.30M	$16.42M	$17.19M	$32.59M	$22.64M	$24.16M	$12.49M	$12.39M	$11.79M	$2.92M	$10.26M	$9.27M	$5.85M	$18.72M	$90.82M	$10.12M	$7.21M	$8.05M	$6.94M	$4.63M	$11.26M	$6.46M	$7.74M
High Forecast	$74.35M	$71.35M	$66.88M	$62.39M	$33.46M	$39.67M	$39.46M	$19.69M	$23.69M	$25.81M	$32.59M	$27.17M	$33.11M	$12.49M	$18.61M	$17.72M	$3.50M	$10.26M	$9.27M	$5.85M	$18.72M	$90.82M	$10.12M	$7.21M	$8.05M	$6.94M	$4.63M	$13.51M	$6.46M	$7.74M
Low Forecast	$31.41M	$30.15M	$28.25M	$26.36M	$14.13M	$16.76M	$16.67M	$6.90M	$12.21M	$10.91M	$32.59M	$18.12M	$11.51M	$12.49M	$7.86M	$7.49M	$2.33M	$10.26M	$9.27M	$5.85M	$18.72M	$90.82M	$10.12M	$7.21M	$8.05M	$6.94M	$4.63M	$9.00M	$6.46M	$7.74M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.88%	1.51%	1.65%	1.55%	8.59%	1.76%	2.04%	3.24%	1.17%	0.24%	1.64%	2.27%	2.49%	2.07%	3.07%	0.94%	1.91%	1.49%

Agenus's average Quarter SG&A projection for Mar 24 is $22.64M, based on 1 Wall Street analysts, with a range of $18.12M to $27.17M. The forecast indicates a 6.93% rise compared to AGEN last annual SG&A of $21.18M (Dec 23).

Agenus EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	4	2	1	1	3	1	1	1	1	1	1	1	1	1	1	1	9	9	9	9	8	8
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.13	$-0.16	$-0.20	$-0.21	$-0.35	$-0.26	$-0.18	$-0.25	$-0.36	$0.76	$-0.37	$-0.27	$-0.19	$-0.28	$-0.28	$-0.31	$-0.21	$-0.33
Avg Forecast	$-1.92	$-2.02	$-2.20	$-2.40	$-2.21	$-1.94	$-1.83	$-2.44	$-2.64	$-2.31	$-1.07	$-3.21	$-1.07	$-3.90	$-3.90	$-4.14	$-4.35	$-3.68	$-4.51	$-5.84	$-3.09	$8.96	$-4.78	$-6.02	$-4.32	$-5.10	$-5.36	$-6.54	$-7.46	$-7.46
High Forecast	$-1.01	$-1.06	$-1.15	$-1.26	$-1.16	$-1.02	$-0.96	$-2.13	$-1.66	$-1.21	$-0.56	$-1.68	$0.36	$-2.05	$-2.05	$-2.17	$-2.28	$-3.68	$-4.51	$-5.84	$-3.09	$8.96	$-4.78	$-6.02	$-4.32	$-5.10	$-5.36	$-6.54	$-7.46	$-7.46
Low Forecast	$-3.17	$-3.33	$-3.63	$-3.96	$-3.66	$-3.21	$-3.02	$-2.90	$-3.07	$-3.82	$-1.76	$-5.30	$-2.67	$-6.45	$-6.45	$-6.85	$-7.19	$-3.68	$-4.51	$-5.84	$-3.09	$8.96	$-4.78	$-6.02	$-4.32	$-5.10	$-5.36	$-6.54	$-7.46	$-7.46
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.12%	0.04%	0.05%	0.05%	0.08%	0.07%	0.04%	0.04%	0.12%	0.08%	0.08%	0.04%	0.04%	0.05%	0.05%	0.05%	0.03%	0.04%

According to 1 Wall Street analysts, Agenus's projected average Quarter EPS for Dec 21 is $-3.09, with a low estimate of $-3.09 and a high estimate of $-3.09. This represents a -506.72% decrease compared to AGEN previous annual EPS of $0.76 (Sep 21).

Agenus Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
ADAP	Adaptimmune Therapeutics	$0.60	$4.00	566.67%	Buy
AFMD	Affimed	$1.51	$7.50	396.69%	Buy
XFOR	X4 Pharmaceuticals	$0.74	$3.67	395.95%	Buy
PDSB	PDS Bio	$1.96	$9.00	359.18%	Buy
ADCT	ADC Therapeutics SA	$2.13	$9.33	338.03%	Buy
AGEN	Agenus	$2.96	$7.33	147.64%	Hold
MREO	Mereo BioPharma Group	$3.40	$8.00	135.29%	Buy
VKTX	Viking Therapeutics	$46.70	$97.80	109.42%	Buy
LPTX	Leap Therapeutics	$3.11	$5.50	76.85%	Buy
EWTX	Edgewise Therapeutics	$30.17	$46.25	53.30%	Buy
MDGL	Madrigal Pharmaceuticals	$306.08	$315.75	3.16%	Buy
TGTX	TG Therapeutics	$33.57	$23.75	-29.25%	Buy

AGEN Forecast FAQ

Is Agenus a good buy?

No, according to 4 Wall Street analysts, Agenus (AGEN) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 25.00% of AGEN's total ratings.

What is AGEN's price target?

Agenus (AGEN) average price target is $7.33 with a range of $7 to $8, implying a 159.01% from its last price of $2.83. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Agenus stock go up soon?

According to Wall Street analysts' prediction for AGEN stock, the company can go up by 159.01% (from the last price of $2.83 to the average price target of $7.33), up by 182.69% based on the highest stock price target, and up by 147.35% based on the lowest stock price target.

Can Agenus stock reach $4?

AGEN's average twelve months analyst stock price target of $7.33 supports the claim that Agenus can reach $4 in the near future.

What is Agenus's current price target trend?

1 Wall Street analyst forecast a $7 price target for Agenus (AGEN) this month, up 147.35% from its last price of $2.83. Compared to the last 3 and 12 months, the average price target increased by 147.35% and increased by 260.42%, respectively.

What are Agenus's analysts' financial forecasts?

Agenus's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $171.91M (high $257.66M, low $106.1M), average EBITDA is $-110M (high $-68.065M, low $-165M), average net income is $-182M (high $-114M, low $-276M), average SG&A $88.25M (high $132.28M, low $54.47M), and average EPS is $-8.423 (high $-5.271, low $-12.789). AGEN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $356.59M (high $535.62M, low $226.29M), average EBITDA is $-229M (high $-145M, low $-344M), average net income is $-184M (high $-96.494M, low $-304M), average SG&A $183.06M (high $274.97M, low $116.17M), and average EPS is $-8.529 (high $-4.478, low $-14.096).

Did the AGEN's actual financial results beat the analysts' financial forecasts?

Based on Agenus's last annual report (Dec 2023), the company's revenue was $785.91M, beating the average analysts forecast of $118.49M by 563.25%. Apple's EBITDA was $0, missing the average prediction of $-101M by -100.00%. The company's net income was $0, missing the average estimation of $-253M by -100.00%. Apple's SG&A was $0, missing the average forecast of $60.83M by -100.00%. Lastly, the company's EPS was $0, missing the average prediction of $-13.011 by -100.00%. In terms of the last quarterly report (Dec 2023), Agenus's revenue was $83.8M, beating the average analysts' forecast of $47.05M by 78.09%. The company's EBITDA was $-4.359M, missing the average prediction of $-30.185M by -85.56%. Agenus's net income was $-48.582M, beating the average estimation of $-23.005M by 111.18%. The company's SG&A was $21.18M, missing the average forecast of $24.16M by -12.33%. Lastly, the company's EPS was $-0.13, missing the average prediction of $-1.067 by -87.82%